MedTrace Logo

Palliative Care and Oncology Survey on Terminology

NCT05871996 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1532

Last updated 2025-06-27

No results posted yet for this study

Summary

The term '"cancer survivors" is widely used but has different definitions. One definition describes "cancer survivors" as individuals from the time of diagnosis throughout their lives, which includes people living with cancer and people free of cancer. The views of some groups included in this definition of "cancer survivors" have rarely been assessed, including those with cancer on anticancer treatment and those known to palliative care. How they view these terms could have important implications for how they receive care services.

This is an international multi-centre observational study. It aims to recruit patients internationally across Ireland and the United Kingdom. Participants known to cancer and/or palliative care hospital or hospice services as inpatients, outpatients or community patients will be asked to complete a survey during a one-off visit which should last under 30 minutes. The survey asks a series of questions to determine the perceptions of patients know to cancer and palliative care services about the terminologies used to describe them.

Conditions

Interventions

OTHER

Palliative Care and Oncology Survey on Terminology (POST)

Each group receives a survey to complete. The only difference between the two is the inclusion criteria; the surveys are the same.

Sponsors & Collaborators

  • Royal Surrey County Hospital NHS Foundation Trust

    collaborator OTHER

  • Our Lady's Hospice and Care Services

    lead OTHER

Principal Investigators

  • Andrew N Davies, MBBS MSc MD · Our Lady's Hospice & Care Services

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05871996 on ClinicalTrials.gov